Abstract
CD200, formerly known as OX-2, is a type I glycoprotein that is expressed on a variety of cell types. CD200 has been shown to be overexpressed in chronic lymphocytic leukemia (CLL). Although previous studies have confirmed the diagnostic value of CD200 in differentiating CLL from to other B-cell chronic lymphoproliferative disorders especially mantle cell lymphoma, whether CD200 has prognostic significance in CLL remains to be determined. We evaluated the mean fluorescence intensity (MFI) of CD200 in 307 consecutive, untreated patients with CLL in our center using flow cytometry. Using a CD200 MFI cutoff of 189.5, these cases could be divided into two groups. Patients with lower CD200 MFI (< 189.5) had a significantly shorter time-to-treatment (TTT) than those with higher CD200 MFI (≥ 189.5) (median TTT: 2 months vs 28 months, p = 0.0008). However, the effect of CD200 MFI on overall survival was not significant (CD200 MFI < 189.5: undefined vs CD200 MFI ≥ 189.5: undefined, P = 0.2379). In subgroup analysis, CD200 MFI retained its prognostic value in patients with favourable characteristics such as Binet stage A disease, mutated IGHV status, normal TP53 or negative CD38 expression. In conclusion, our study identified CD200 MFI a...Continue Reading
References
Jan 25, 2002·Blood·Terry J HamblinDavid G Oscier
Jun 20, 2002·Trends in Immunology·A Neil BarclayMarion H Brown
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Jun 21, 2005·The Journal of Clinical Investigation·Güllü GörgünJohn G Gribben
Jan 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·John R McWhirterKatherine S Bowdish
Sep 2, 2006·Blood·Jerome MoreauxBernard Klein
Jan 26, 2007·Leukemia·A TonksR L Darley
Nov 24, 2007·Leukemia Research·Wei XuHong-Xia Qiu
Jan 25, 2008·Blood·Michael HallekUNKNOWN International Workshop on Chronic Lymphocytic Leukemia
Oct 8, 2008·Leukemia Research·Christian P PallaschClemens-Martin Wendtner
Feb 24, 2009·Leukemia Research·Giuseppe A PalumboFrancesco Di Raimondo
Apr 7, 2009·British Journal of Haematology·Lorenzo BrunettiLuigi Del Vecchio
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
May 6, 2010·Journal of Leukocyte Biology·Karrie K WongReginald M Gorczynski
Nov 30, 2010·Annals of Hematology·Hua-Jie DongJian-Yong Li
Nov 9, 2011·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Nermeen Ahmed El DesoukeyRasha Faragaly Mohammed
Dec 20, 2011·American Journal of Clinical Pathology·Daisy AlapatRobert B Lorsbach
May 7, 2013·Leukemia Research·Tal TwitoReg Gorczynski
Sep 17, 2013·Cytometry. Part B, Clinical Cytometry·Alex F SandesEdgar G Rizzatti
May 2, 2014·Blood·Alejandra Martínez-TrillosNeus Villamor
Jun 25, 2014·Journal of Clinical Pathology·Jonathan J DoudsShaoying Li
Nov 13, 2014·American Journal of Clinical Pathology·Pramoda ChallagundlaJeffrey L Jorgensen
Dec 3, 2014·JAMA : the Journal of the American Medical Association·Chadi Nabhan, Steven T Rosen
Jan 22, 2015·Oncotarget·Yi XiaJian-Yong Li
Mar 21, 2015·Leukemia & Lymphoma·Lei FanJian-Yong Li
Citations
Aug 20, 2019·Hematological Oncology·Yi-Xin ZouJian-Yong Li
Nov 23, 2017·Hematology·Salah ArefMohamed Mabed
Oct 5, 2016·Oncology Letters·Zheng GeChunhua Song
Dec 16, 2017·Blood Cancer Journal·Shu-Chao QinChun Qiao
May 8, 2018·Annals of Hematology·Yuqing MiaoJian-Yong Li
Dec 17, 2020·Frontiers in Oncology·Giovanni D'ArenaLuca Laurenti
Mar 9, 2021·Pathology·Anya K HotinskiBryone J Kuss
Jul 15, 2021·Experimental Hematology & Oncology·Panruo JiangHaige Ye